Tryptamine Therapeutics Limited (ASX:TYP)

Tryptamine Therapeutics Statistics

Total Valuation

ASX:TYP has a market cap or net worth of AUD 43.20 million. The enterprise value is 40.17 million.

Market Cap	43.20M
Enterprise Value	40.17M

Important Dates

The next estimated earnings date is Tuesday, September 30, 2025.

Earnings Date	Sep 30, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:TYP has 1.44 billion shares outstanding. The number of shares has increased by 295.36% in one year.

Current Share Class	1.44B
Shares Outstanding	1.44B
Shares Change (YoY)	+295.36%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	32.19%
Owned by Institutions (%)	2.81%
Float	878.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	27.31
PB Ratio	7.24
P/TBV Ratio	7.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.53
EV / Sales	25.40
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.09

Financial Position

The company has a current ratio of 9.08

Current Ratio	9.08
Quick Ratio	8.28
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-678.55

Financial Efficiency

Return on equity (ROE) is -92.06% and return on invested capital (ROIC) is -54.61%.

Return on Equity (ROE)	-92.06%
Return on Assets (ROA)	-45.59%
Return on Invested Capital (ROIC)	-54.61%
Return on Capital Employed (ROCE)	-86.32%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.22
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +63.16% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+63.16%
50-Day Moving Average	0.03
200-Day Moving Average	0.04
Relative Strength Index (RSI)	43.48
Average Volume (20 Days)	1,670,439

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:TYP had revenue of AUD 1.58 million and -5.33 million in losses. Loss per share was -0.00.

Revenue	1.58M
Gross Profit	-816,894
Operating Income	-5.15M
Pretax Income	-5.33M
Net Income	-5.33M
EBITDA	-5.09M
EBIT	-5.15M
Loss Per Share	-0.00

Balance Sheet

The company has 3.03 million in cash and n/a in debt, giving a net cash position of 3.03 million or 0.00 per share.

Cash & Cash Equivalents	3.03M
Total Debt	n/a
Net Cash	3.03M
Net Cash Per Share	0.00
Equity (Book Value)	5.96M
Book Value Per Share	0.00
Working Capital	5.65M

Cash Flow

In the last 12 months, operating cash flow was -7.77 million and capital expenditures -129,281, giving a free cash flow of -7.90 million.

Operating Cash Flow	-7.77M
Capital Expenditures	-129,281
Free Cash Flow	-7.90M
FCF Per Share	-0.01

Margins

Gross Margin	-51.65%
Operating Margin	-325.49%
Pretax Margin	-337.14%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASX:TYP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-295.36%
Shareholder Yield	n/a
Earnings Yield	-12.34%
FCF Yield	-18.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:TYP has an Altman Z-Score of 25.83 and a Piotroski F-Score of 1.

Altman Z-Score	25.83
Piotroski F-Score	1